TB-500 is commonly referenced as a synthetic, N-acetylated heptapeptide fragment linked to thymosin β4 fragment research. In preclinical contexts, it’s discussed in relation to actin-binding/cytoskeletal signaling, cell migration, and tissue repair pathways. Because the term “TB-500” is used inconsistently in marketplaces, always anchor your listing to the exact sequence and documentation.
“BPC-157” has been added to your cart. View cart
TB-500
A synthetic heptapeptide linked to thymosin β4 fragment research. Explored preclinically in cell migration, cytoskeletal, and repair models.
| Target | |
|---|---|
| Route | Subcutaneous |
